About Ciganek LLC
Services
Type of Care
Substance use treatment; Detoxification
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient detoxification; Outpatient methadone/buprenorphine or naltrexone treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification; Buprenorphine maintenance; Buprenorphine maintenance for predetermined time; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Lofexidine/clonidine detoxification
Pharmacotherapies
Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine
Facility Operation (e.g., Private, Public)
Private for-profit organization
License/Certification/Accreditation
State Substance use treatment agency; State mental health department; State department of health; SAMHSA certification for opioid treatment program (OTP)
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Cash or self-payment
Assessment/Pre-treatment
Comprehensive substance use assessment; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use
Testing
Drug and alcohol oral fluid testing; Drug or alcohol urine screening
Transitional Services
Naloxone and overdose education
Detoxification (medical withdrawal) Services
Alcohol Detoxification; Benzodiazepines Detoxification; Opioids detoxification; Medication routinely used during detoxification
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Adults; Young adults
Gender Accepted
Female; Male
Facility Vaping Policy
Vaping not permitted
